11-73309298-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014786.4(ARHGEF17):āc.660C>Gā(p.Phe220Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,459,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014786.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF17 | NM_014786.4 | c.660C>G | p.Phe220Leu | missense_variant | 1/21 | ENST00000263674.4 | NP_055601.2 | |
ARHGEF17-AS1 | NR_147696.1 | n.64G>C | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF17 | ENST00000263674.4 | c.660C>G | p.Phe220Leu | missense_variant | 1/21 | 1 | NM_014786.4 | ENSP00000263674 | P1 | |
ARHGEF17-AS1 | ENST00000546324.1 | n.64G>C | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244758Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133546
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459962Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726260
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2023 | The c.660C>G (p.F220L) alteration is located in exon 1 (coding exon 1) of the ARHGEF17 gene. This alteration results from a C to G substitution at nucleotide position 660, causing the phenylalanine (F) at amino acid position 220 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at